MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST— 510(k) K033982
Substantially EquivalentVysis
FDA 510(k) clearance K033982 for MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST, Substantially Equivalent on 2004-01-22. Applicant: Vysis.
Clearance details
- Applicant
- Vysis
- Product code
- Code MMW
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Downers Grove, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.